Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP285147.RAS6WoEo-3s9ilRAQWxo35Vg_bed8C37PzZNBN_tM1Lqk130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285147.RAS6WoEo-3s9ilRAQWxo35Vg_bed8C37PzZNBN_tM1Lqk130_provenance.
• assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP488985.RAmZWhMtqJCZ1d4lsZtggACWpL6VCTHHY61k7_4cpytcU130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488985.RAmZWhMtqJCZ1d4lsZtggACWpL6VCTHHY61k7_4cpytcU130_provenance.
• assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP307586.RAAVTakjItRnBer-r8uW7iq6IQ2fjMr2uLt1Cqtn1YM9Y130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307586.RAAVTakjItRnBer-r8uW7iq6IQ2fjMr2uLt1Cqtn1YM9Y130_provenance.
• NP307587.RADc3B3yULCiGsCJVplBBwGXXsVThKgzM6qlOSeIXbCUk130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307587.RADc3B3yULCiGsCJVplBBwGXXsVThKgzM6qlOSeIXbCUk130_provenance.
• NP307582.RAQtkkpmLgVjjuvsOJ6Fs_tXwOmCBHsG7woUn1eSERT18130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307582.RAQtkkpmLgVjjuvsOJ6Fs_tXwOmCBHsG7woUn1eSERT18130_provenance.
• NP431296.RAu6Dr1GuXJB7Bae0pVFX-GZV1QI2LHQywhVY5lMFnUSs130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431296.RAu6Dr1GuXJB7Bae0pVFX-GZV1QI2LHQywhVY5lMFnUSs130_provenance.
• NP470064.RAusGoq4g1ScrF_x8j34CdYcbuRGYLnunODtRSli5m9iI130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470064.RAusGoq4g1ScrF_x8j34CdYcbuRGYLnunODtRSli5m9iI130_provenance.
• NP431289.RALUzmqC0KvDmI7ap6uBAbrBEs0T-QJfnoi2VJyN4gYZk130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431289.RALUzmqC0KvDmI7ap6uBAbrBEs0T-QJfnoi2VJyN4gYZk130_provenance.
• NP243336.RAEaGAbucE0P3COqLF5EDzXyoDKXsHzqCULbPome-HW60130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243336.RAEaGAbucE0P3COqLF5EDzXyoDKXsHzqCULbPome-HW60130_provenance.
• NP469952.RAHg3uUccUvJqZPS8YNCkEUVN3mqH-TaoKPUVNinwUe08130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469952.RAHg3uUccUvJqZPS8YNCkEUVN3mqH-TaoKPUVNinwUe08130_provenance.
• NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307581.RA4JLLrHJ9KGCgDXqB1Vb-4GLcQhoF48LNxCbs003fXrI130_provenance.
• NP307584.RA1Munr-dz2DfMb_vgi5HuanAHZilHMZDXmM5rFk7q83c130_assertion description "[We conclude that PLC and PLD activities are required for apoA-I-mediated cellular cholesterol efflux, and modulating cellular PA concentration can correct, at least partially, the cholesterol efflux defect in FHD and TD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307584.RA1Munr-dz2DfMb_vgi5HuanAHZilHMZDXmM5rFk7q83c130_provenance.